Wegovy is an injectable medication containing semaglutide, classified as a GLP-1 receptor agonist. It is prescribed for chronic weight management in adults with obesity or those who are overweight with related health conditions. Semaglutide works by mimicking the hormone GLP-1, which helps regulate appetite and food intake, leading to reduced hunger and increased feelings of fullness. When used alongside a healthy diet and physical activity, Wegovy can support significant weight loss

The amount of weight you may lose while using Wegovy (semaglutide) can vary from person to person. Clinical studies have shown that adults using Wegovy for chronic weight management can experience an average weight reduction of around 15% of their starting weight. However, individual results can differ based on factors like response to the medication, consistency with treatment, lifestyle changes, metabolic rate, and overall health. Some people may achieve greater weight loss, while others may see more gradual results

Typical side effects of Wegovy can include digestive discomfort (such as nausea, vomiting, diarrhea), low blood sugar (hypoglycemia), injection site reactions, and reduced appetite. These symptoms often improve over time. For instance, nausea may be minimized by taking Wegovy with food or before bed. Staying hydrated and adjusting the timing of the injection can also help ease digestive issues. If side effects persist or worsen, it’s recommended to consult a healthcare professional for guidance